The National Institute of Allergy and Infectious Diseases has recently established the COVID-19 Prevention Network (CoVPN), with a goal to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19. As part of this initiative, Oracle has developed a Cloud System called the CoVPN Volunteer Screening Registry to identify and screen volunteers who want to participate in COVID-19 clinical trials.
For more information, click here.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.